Condition
Oxydative Stress
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed2
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07029048Completed
Oxidative Stress and Cognitive Dysfunction After COVID-19
NCT06980896Not Yet Recruiting
Physical Activity Oxidative Stress and Inflammation With Ageing
NCT06942650Completed
The Effect of Prolonged ischemıa and anesthetıc Agents on Oxidative Stress
NCT02176109Unknown
Metabolism Des LAM
Showing all 4 trials